Haemonetics Corporation News Headlines

HAE 
$38.41
*  
0.30
0.79%
Get HAE Alerts
*Delayed - data as of Dec. 26, 2014  -  Find a broker to begin trading HAE now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
BioCryst Rises on Positive Ebola Candidate Results - Analyst Blog
12/26/2014 3:00:00 PM - Zacks.com


Haemonetics Q2 Results Let Down by Poor Disposables Show - Analyst Blog
12/26/2014 2:40:00 PM - Investopedia


Haemonetics Q2 Results Let Down by Poor Disposables Show - Analyst Blog
12/26/2014 2:40:00 PM - Zacks.com


Haemonetics Corporation (HAE): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
12/18/2014 7:00:00 AM - Investopedia


Haemonetics (HAE) Upgraded From Hold to Buy
12/13/2014 8:20:00 AM - TheStreet


Haemonetics To Present At Jefferies Global Conference; Webcast At 3:40 AM ET
11/20/2014 2:40:00 AM - RTT News


Update: Haemonetics Needs A Sales Growth Infusion Following Q3 Sales Miss And EPS Beat
11/5/2014 9:56:00 AM - Seeking Alpha


Haemonetics Q2 Earnings Beat Estimates but Decline Y/Y - Analyst Blog
11/4/2014 1:20:00 PM - Zacks.com


Haemonetics Breaks Below 200-Day Moving Average - Notable for HAE
11/3/2014 4:00:48 PM - BNK Invest


Sector Update: Health Stocks Flat Pre-Bell
11/3/2014 8:46:15 AM - MT Newswires


Sector Update: Health Care
11/3/2014 8:45:35 AM - MT Newswires


Haemonetics Corp. Q2 15 Earnings Conference Call At 8:00 AM ET
11/3/2014 7:01:00 AM - RTT News


Is Haemonetics (HAE) Poised to Beat on Q2 Earnings? - Analyst Blog
10/30/2014 5:15:00 PM - Zacks.com


Perrigo Sells Some Assets to Imago Pharmaceuticals - Analyst Blog
10/3/2014 3:45:00 PM - Zacks.com


Walgreens Earnings in Line, Alliance Boots Shows Synergy - Analyst Blog
9/30/2014 9:45:00 AM - Zacks.com


Haemonetics (HAE) Poised on Strong Q2, Optimistic Outlook - Analyst Blog
9/19/2014 5:00:00 PM - Zacks.com


Salix Pharmaceuticals Beats on Q2 Earnings, Cuts Guidance - Analyst Blog
8/12/2014 8:20:00 AM - Zacks.com


Update: Haemonetics Earnings-Revenue Growth And Shrinking Loss As Restructuring Progresses
8/5/2014 1:31:00 PM - Seeking Alpha


Haemonetics Tops Q1 Earnings and Revenues, Guidance Retained - Analyst Blog
8/1/2014 2:00:00 PM - Zacks.com


Guru Held Stocks Near Historical Low P/B
7/22/2014 6:48:58 PM - GuruFocus


Shire's Q2 Earnings Strong but Overshadowed by AbbVie Deal - Analyst Blog
7/22/2014 10:01:00 AM - Zacks.com


Salix-Pharming's Ruconest Gets FDA Nod for HAE - Analyst Blog
7/18/2014 5:00:00 PM - Zacks.com


Haemonetics (HAE) is in Overbought Territory: What's Next? - Tale of the Tape
6/30/2014 8:55:33 AM - Zacks.com


Haemonetics Suffers on Dismal Q4, Poor FY15 Outlook - Analyst Blog
6/27/2014 1:55:00 PM - Zacks.com


Isis Shines, PTC Therapeutics Soars - Analyst Blog
5/28/2014 10:16:00 AM - Zacks.com